Nuformix (LSE:NFX) Total Equity : £4.59 Mil (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Total Equity?

Nuformix's total equity for the quarter that ended in Sep. 2022 was £4.59 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nuformix Total Equity Historical Data

The historical data trend for Nuformix's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Equity Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Total Equity

Get a 7-Day Free Trial

4.49

3.82

4.74

5.69

4.74

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Total Equity	Get a 7-Day Free Trial									5.69	5.25	4.74	4.59	4.23

Nuformix Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nuformix's Total Equity for the fiscal year that ended in Mar. 2022 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2022 )	-	Total Liabilities(Q: Mar. 2022 )
	=	4.976	-	0.238
	=	4.74

Nuformix's Total Equity for the quarter that ended in Sep. 2022 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2022 )	-	Total Liabilities(Q: Sep. 2022 )
	=	4.78	-	0.188
	=	4.59

Nuformix Total Equity Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.